Showing results (461-470 of 516) with videos related to
Sort By:
Pageof 52
Acta Neuropathologica|February 24, 2012
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasMarcel Kool, Andrey Korshunov, Marc Remke, et al.Neuro-Oncology|April 17, 2021
Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastomaMatthias Schneider, Lea Vollmer, Anna-Laura Potthoff, et al.Neuro-Oncology|November 2, 2020
Second series by the Italian Association of Pediatric Hematology and Oncology of children and adolescents with intracranial ependymoma: an integrated molecular and clinical characterization with a long-term follow-upMaura Massimino, Francesco Barretta, Piergiorgio Modena, et al.Annals of the Rheumatic Diseases|March 27, 2025
Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stagesLavinia Agra Coletto, Hanna W van Steenbergen, Clara Di Mario, et al.Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.Brain Pathology (Zurich, Switzerland)|October 23, 2024
CIC/ATXN1-rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic seriesArnault Tauziède-Espariat, Azadeh Ebrahimi, Nathalie Boddaert, et al.Neuro-Oncology|October 11, 2017
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)Dagmar Beier, Martin Proescholdt, Christiane Reinert, et al.Nature Communications|April 8, 2026
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trialFrank A Giordano, Julian P Layer, Roberta Turiello, et al.Nature Medicine|July 1, 2020
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritisStefano Alivernini, Lucy MacDonald, Aziza Elmesmari, et al.Pageof 52